CFO & EVP of Corp. Development · Milestone Pharmaceuticals Inc. · Common Shares
Side
SELL
Value
$135K
Shares
58.0K
Price
$2.32
Executed
Dec 15, 2025
Disclosed
Jan 28, 2026
Disclosure timeline44 days from execution to publication · legal deadline 2 business days
Dec 15 executedJan 28, 2026 disclosed
MIST · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 32 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Hasija Amit filed this Form 4 reporting a open-market sale of MIST on Dec 15, 2025. It became public on Jan 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CFO & EVP of Corp. Development
Hasija Amitcik:0001787700
Issuer
Milestone Pharmaceuticals Inc.cik:0001408443
Revision history · 0
No field has changed since this record was first ingested.
